I‐Fang Hsin

652 total citations
33 papers, 502 citations indexed

About

I‐Fang Hsin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, I‐Fang Hsin has authored 33 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 19 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in I‐Fang Hsin's work include Liver Disease and Transplantation (23 papers), Liver Disease Diagnosis and Treatment (19 papers) and Organ Transplantation Techniques and Outcomes (6 papers). I‐Fang Hsin is often cited by papers focused on Liver Disease and Transplantation (23 papers), Liver Disease Diagnosis and Treatment (19 papers) and Organ Transplantation Techniques and Outcomes (6 papers). I‐Fang Hsin collaborates with scholars based in Taiwan, United States and China. I‐Fang Hsin's co-authors include Hui‐Chun Huang, Han‐Chieh Lin, Fa‐Yauh Lee, Shou‐Dong Lee, Shao‐Jung Hsu, Chiao‐Lin Chuang, Ching-Chih Chang, Ekihiro Seki, Sun-Sang Wang and Teh‐Ia Huo and has published in prestigious journals such as Hepatology, Journal of Pharmacology and Experimental Therapeutics and Science Translational Medicine.

In The Last Decade

I‐Fang Hsin

32 papers receiving 495 citations

Peers

I‐Fang Hsin
Roman Liebe Germany
I‐Fang Hsin
Citations per year, relative to I‐Fang Hsin I‐Fang Hsin (= 1×) peers Roman Liebe

Countries citing papers authored by I‐Fang Hsin

Since Specialization
Citations

This map shows the geographic impact of I‐Fang Hsin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Fang Hsin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Fang Hsin more than expected).

Fields of papers citing papers by I‐Fang Hsin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Fang Hsin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Fang Hsin. The network helps show where I‐Fang Hsin may publish in the future.

Co-authorship network of co-authors of I‐Fang Hsin

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Fang Hsin. A scholar is included among the top collaborators of I‐Fang Hsin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Fang Hsin. I‐Fang Hsin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yen‐Po, I‐Fang Hsin, Ping‐Hsien Chen, et al.. (2024). Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients. Esophagus. 21(2). 131–140.
2.
Wang, Qinglan, Zhijun Wang, Mingyi Xu, et al.. (2020). Neurotropin Inhibits Lipid Accumulation by Maintaining Mitochondrial Function in Hepatocytes via AMPK Activation. Frontiers in Physiology. 11. 950–950. 5 indexed citations
3.
Hsin, I‐Fang, et al.. (2020). The indocyanine green retention test as a noninvasive marker for esophageal varices in patients with hepatocellular carcinoma. Journal of the Chinese Medical Association. 83(8). 737–742. 2 indexed citations
4.
Hsin, I‐Fang, Hui‐Chun Huang, Ching-Chih Chang, et al.. (2018). Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes. Clinical Science. 132(22). 2391–2405. 3 indexed citations
5.
Chen, Ping‐Hsien, Chien‐Wei Su, Ming‐Chih Hou, et al.. (2018). Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices. Gastrointestinal Endoscopy. 88(2). 230–239.e2. 27 indexed citations
6.
Jiang, Jeng‐Kai, Jiing‐Chyuan Luo, Ping‐Hsien Chen, et al.. (2018). The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes. Journal of the Chinese Medical Association. 81(9). 759–765. 6 indexed citations
7.
Chang, Ching-Chih, Wen-Shin Lee, Chiao‐Lin Chuang, et al.. (2018). Effect of ivabradine, a funny current inhibitor, on portal hypertensive rats. Journal of the Chinese Medical Association. 82(1). 19–24. 2 indexed citations
8.
Huang, Hui‐Chun, Ting Chang, Wen-Shin Lee, et al.. (2018). Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats. European Journal of Pharmacology. 824. 133–139. 8 indexed citations
9.
Huang, Hui‐Chun, Wen-Shin Lee, Chiao‐Lin Chuang, et al.. (2017). Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats. Journal of the Chinese Medical Association. 80(8). 467–475. 13 indexed citations
10.
Chang, Ching-Chih, Wen-Shin Lee, Chiao‐Lin Chuang, et al.. (2017). Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats. European Journal of Pharmacology. 802. 36–43. 8 indexed citations
11.
Hsu, Shao‐Jung, Fa‐Yauh Lee, Hui‐Chun Huang, et al.. (2016). Role of cyclooxygenase isoforms in encephalopathy of cirrhotic rats. Journal of the Chinese Medical Association. 79(11). 583–588. 1 indexed citations
12.
Hou, Ming‐Chih, Ping‐Hsien Chen, I‐Fang Hsin, et al.. (2015). Clinical Outcomes and Complications of Endoscopic Submucosal Dissection for Superficial Gastric Neoplasms in the Elderly. Medicine. 94(44). e1964–e1964. 14 indexed citations
13.
Hsu, Shao‐Jung, Sun-Sang Wang, Teh‐Ia Huo, et al.. (2015). The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats. Journal of Pharmacology and Experimental Therapeutics. 355(1). 117–124. 7 indexed citations
14.
Hsin, I‐Fang, Teh‐Ia Huo, Fa‐Yauh Lee, et al.. (2015). 2'‐Hydroxyflavanone ameliorates mesenteric angiogenesis and portal‐systemic collaterals in rats with liver fibrosis. Journal of Gastroenterology and Hepatology. 31(5). 1045–1051. 6 indexed citations
15.
Hsu, Shao‐Jung, I‐Fang Hsin, Hui‐Chun Huang, et al.. (2013). Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats. Scandinavian Journal of Gastroenterology. 48(7). 831–838. 10 indexed citations
16.
Hsu, Shao‐Jung, I‐Fang Hsin, Yi‐Ling Lin, et al.. (2012). The influence of sorafenib on hepatic encephalopathy and the mechanistic survey in cirrhotic rats. European Journal of Clinical Investigation. 42(12). 1309–1316. 12 indexed citations
17.
Huang, Hui‐Chun, et al.. (2012). A patient with hemodialysis-related hyperammonemic encephalopathy: a delayed presentation of congenital arterioportal fistulas. Clinical Nephrology. 79(6). 499–503. 4 indexed citations
18.
Huang, Hui‐Chun, Sun-Sang Wang, I‐Fang Hsin, et al.. (2012). Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. Hepatology. 56(1). 248–258. 59 indexed citations
19.
Hsin, I‐Fang, Hui‐Chun Huang, Yi‐Hsiang Huang, et al.. (2011). Liver Failure After Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma and Ascites. Journal of Clinical Gastroenterology. 45(6). 556–562. 45 indexed citations
20.
Hsin, I‐Fang, Sun-Sang Wang, Hui‐Chun Huang, et al.. (2011). Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats. Journal of the Chinese Medical Association. 75(1). 3–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026